Marc C. Smaldone, MD, MSHP, FACS

Request an Appointment

Call 888-369-2427

Request Online

Clinical Locations

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Phone: 888-369-2427
Fox Chase Cancer Center - Huntingdon Pike
8 Huntingdon Pike
Rockledge, PA 19046
Phone: 888-369-2427

Director, Surgical Quality, Department of Urology

Professor of Urology

Specialties

Urology

Areas of Expertise

Penile Cancer, Ureteral Cancer, Kidney Cancer, Testicular Cancer, Bladder Cancer, Prostate Cancer, Urethral Cancer, Adrenal Tumor

Treatment Focus

Robotic and laparoscopic minimally invasive surgery
Continent urinary diversion
Salvage and reconstructive Surgery

Research Program

Cancer Prevention and Control

Distinctions

Treatment Philosophy

I am a urologic oncologist specializing in the surgical management of tumors of the kidney, bladder, prostate, adrenal, testis and other genitourinary organs. As part of the multi-disciplinary Genitourinary Cancer Patient Care Team, I work closely with my colleagues in Medical and Radiation Oncology to develop a comprehensive treatment plan that offers the best chance for cure for each patient.

The mission at the Fox Chase Cancer Center is to deliver world class oncologic care in the most compassionate and respectful way possible. A cancer diagnosis brings fear and uncertainty for patients and their families, and my personal philosophy is to treat patients how I would wish for my family members to be treated. Patient education is essential, and I consider it of utmost importance to take the time necessary for patients to understand and feel comfortable with all possible treatment options to inspire confident decision making.

I have expertise in open, laparoscopic, and robotic surgical techniques, which allows me to tailor a specific treatment plan based on individual patient need and preferences. I have particular expertise in minimally invasive organ preserving and reconstructive techniques to preserve function and quality of life, including nerve-sparing prostatectomy for patients with prostate cancer and partial nephrectomy for patients with kidney cancer. I have experience performing both robotic and open cystectomy for patients with bladder cancer, and prefer to construct continent urinary diversions whenever possible. I have a clinical interest in the surgical management of patients with high risk and advanced disease, and have experience performing retroperitoneal lymph node dissection following chemotherapy in patients with testicular cancer, cytoreductive nephrectomy and thrombectomy for patients with metastatic kidney cancer or tumors extending into the vena cava, and salvage surgery following radiation for patients with bladder or prostate cancer.

Follow on Twitter: @FCUroOnc

Educational Background

Fellowship: Urologic Oncology, Fox Chase Cancer Center, Philadelphia, PA
Residency: Urologic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA
MS, Health Policy Research, University of Pennsylvania, Philadelphia, PA
MD, State University of New York at Stony Brook School of Medicine, Stony Brook, NY

Certifications

American Board of Urology

Memberships

National Comprehensive Cancer Network (NCCN)
- Prostate Cancer Early Detection Panel
American Urological Association
Society of Urologic Oncology

Honors & Awards

Philadelphia Magazine Top Doctors, 2023-2024
Main Line Today Top Doctors, 2018-2019

Research Interests

Quality of care
Comparative effectiveness
Risk assessment
Access disparities
Surgical outcomes
Health services research

Selected Publications

Masic S.,Smaldone M.C., Robotic renal surgery for renal cell carcinoma with inferior vena cava thrombus. Transl Androl Urol. 10(5): 2195-2198, 2021. PMC8185684. https://www.ncbi.nlm.nih.gov/pubmed/34159102.

Smaldone M.C., Tomaszewski J.J., Current controversies in minimally invasive urologic oncology. Transl Androl Urol. 10(5): 2149-2150, 2021.PMC8185655 (available at http://dx.doi.org/10.21037/tau-21-258). https://www.ncbi.nlm.nih.gov/pubmed/34159096.

Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, Uzzo RG, Viterbo R, Greenberg RE, Smaldone MC. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. J Urol, 199(5):1238-44, 2018. PubMed

Goel N, Manstein SM, Ward WH, DeMora L, Smaldone MC, Farma JM, Uzzo RG, Esnaola NF. Does the Surgical Apgar Score predict serious complications after elective major cancer surgery? Journal of Surgical Research, 231:242-7, 2018.

Smaldone, M.C., Corcoran, A.T., Hayn M.H., Konety, B.R., Hrebinko Jr., R.L., Davies, B.J. (2009). Estimation of mortality and morbidity risk in patients undergoing radical cystectomy with continent diversion using the POSSUM and Portsmouth POSSUM predictor equations. J Urol,182(6): 2619-24. PubMed

Smaldone, M.C., Cowan, J., Carroll, P.R., Davies, B.J. (2010). Comparison of eligibility for active surveillance and pathologic outcomes in men undergoing radical prostatectomy in a large community-based cohort. J Urol,183(1):138-43. PubMed

Kutikov, A., Smaldone, M.C., Egleston, B.L., Manley, B.J., Simhan, J., Boorjian, S.A., Viterbo, R., Chen, D.Y., Greenberg, R.E., Uzzo, R.G. (2011). Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephromety Score. Eur Urol, 60(2): 241-8. PubMed

Smaldone, M.C., Kutikov, A., Egleston, B., Simhan, J., Canter, D.J., Teper, E., Viterbo, R., Chen, D.Y., Greenberg, R.E., Uzzo, R.G. (2012). Assessing performance trends in laparoscopic nephrectomy and nephron sparing surgery for localized renal tumors. Urology, 80(2): 286-92. PubMed

Smaldone, M.C., Kutikov, A., Egleston, B.L., Canter, D.J., Viterbo, R., Chen, D.Y., Jewett, M.A., Greenberg, R.E., Uzzo, R.G. (2012). Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer, 118(4):997-1006. PubMed

Smaldone, M.C., Egleston, B.L., Uzzo, R.G., Kutikov, A. (2012). Does partial nephrectomy result in a durable overall survival benefit in the Medicare population? J Urol 188(6): 2089-94. PubMed

... Expand

Kutikov, A., Egleston, B.L., Canter, D., Smaldone, M.C., Wong, Y.N., Uzzo, R.G. (2012). Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. J Urol, 188(6): 2077-83. PubMed

Smaldone, M.C., Simhan, J., Kutikov, A., Canter, D.J., Starkey, R., Zhu, F., Nielsen, M.E., Stitzenberg, K.B., Greenberg, R.E., Uzzo, R.G. (2013) Trends in regionalization of radical cystectomy in three large northeastern states from 1996 to 2009. Urol Oncol, 31(8): 1663-9. PubMed

Tomaszewski, J.J., Uzzo, R.G., Handorf, E.A., Bekelman, J.E., Corcoran, A.T., Kutikov, A., Mehrazin, R., Smaldone, M.C. (2014) Care transitions between hospitals are associated with treatment delays for patients with muscle invasive bladder cancer. J Urol, 192(5): 1349-54. PubMed

Kim, S.P, Gross, C.P., Nguyen, P.L., Smaldone, M.C., Shah, N.D., Karnes, R.J., Thompson, R.H., Hand, L.C., Yu, J.B., Trinh, Q.D., Ziegenfuss, J.Y., Sun, M., Tilburt, J.C. (2014) Perceptions of active surveillance and treatment recommendations for low-risk prostate cancer: Results from a national survey of radiation oncologists and urologists. Med Care, 52(7):579-85. PubMed

Martin, J.M., Handorf, E.A., Kutikov, A., Uzzo, R.G., Bekelman, J.E., Horwitz, E.M., Smaldone, M.C. (2014) The rise and fall of prostate brachytherapy: Use of brachytherapy in the treatment of localized prostate cancer in the National Cancer Database. Cancer, 120(14):2114-21. PubMed

Corcoran, A.T., Handorf, E, Canter, D, Tomaszewski, J.J., Bekelman, J.E., Kim, S.P., Uzzo, R.G., Kutikov. A, Smaldone, M.C. (2015) Variation in performance of candidate surgical quality measures for muscle invasive bladder cancer by hospital type. BJU Int, 115(2):230-7. PubMed

Wang, E.H., Gross, C.P., Tilburt, J.C., Yu, J.B., Nguyen, P.L., Smaldone, M.C., Shah, N.D., Abouassally, R., Sun, M., Kim, S.P. Shared decision making and use of decision AIDS for localized prostate cancer: perceptions from radiation oncologists and urologists. (2015) JAMA Intern Med, 175(5):792-9. PubMed Collapse

Additional Publications

My NCBI

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Overall Care

4.9

Explained Things Clearly

4.9

Showed Courtesy & Respect

5.0

Discussed Treatment Options

4.9

Recommend Provider

5.0

Patient comments

4.9 out of 5 (897 ratings, 183 comments)

12/11/2024

I could not be happier with the care I am receiving from Dr. Smaldone and his entire office! While I hate why I am there (prostate cancer) I truly believe that I am in the best possible place to deal with these challenges and again, I could not be happier with the care I am receiving from this team! [...] I never call the office. I just use the health portal. It works great. It looks like the portal messages are screened by someone who really knows what they are doing. If it is an issue that Dr. Smaldone needs to chime in on, he responds in a very timely manner. If it is something that Dr. Smaldone doesn't really need to respond to directly, I always receive a timely response, and the response is always complete and accurate. For me, this is actually much better than calling the office. [...]

12/11/2024

Doctor Smaldone was very respectful and professional. He took the time to go over all my options before my surgery. Once I agreed to surgery he did a great job. He assured me my ability to reach him at any time. His staff was also respectful and professional, Everyone that I encountered at Fox Chase treated me like a person not just a patient. I already recommended a family member. He had a consultation appointment with Dr. Smaldone last week.

12/10/2024

Dr. Smaldone is the best of best not only as Doctor but as a human being who cares about his patients.

12/09/2024

Everyone on Dr. Smaldone's team was very professional well knowledgeable and very concerned about my wellbeing. Everyone ROCK. Me and my family Thank you all very much.